Strategy for the isolation, derivatization, chromatographic separation, and detection of carnitine and acylcarnitinesMINKLER, Paul E; INGALLS, Stephen T; HOPPEL, Charles L et al.Analytical chemistry (Washington, DC). 2005, Vol 77, Num 5, pp 1448-1457, issn 0003-2700, 10 p.Article

A phase IB clinical and pharmacokinetic study of the angiogenesis inhibitor SU5416 and paclitaxel in recurrent or metastatic carcinoma of the head and neckCOONEY, Matthew M; TSERNG, Kou-Yi; IVY, Percy et al.Cancer chemotherapy and pharmacology. 2005, Vol 55, Num 3, pp 295-300, issn 0344-5704, 6 p.Article

Quantification of Carnitine and Acylcarnitines in Biological Matrices by HPLC Electrospray Ionization-Mass SpectrometryMINKLER, Paul E; STOLL, Maria S. K; INGALLS, Stephen T et al.Clinical chemistry (Baltimore, Md.). 2008, Vol 54, Num 9, pp 1451-1462, issn 0009-9147, 12 p.Article

A phase I and pharmacodynamic study of Fludarabine, carboplatin, and topotecan in Patients with relapsed, refractory, or high-risk acute leukemiaCOOPER, Brenda W; VEAL, Gareth J; GOSKY, David et al.Clinical cancer research. 2004, Vol 10, Num 20, pp 6830-6839, issn 1078-0432, 10 p.Article

A phase I and pharmacodynamic study of sequential topotecan and etoposide in patients with relapsed or refractory acute myelogenous and lymphoblastic leukemiaCOOPER, Brenda W; DONAHER, Erin; GERSON, Stanton L et al.Leukemia research. 2003, Vol 27, Num 1, pp 35-44, issn 0145-2126, 10 p.Article

Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabineKRISHNAMURTHI, Smitha S; BRELL, Joanna M; COONEY, Matthew M et al.Cancer chemotherapy and pharmacology. 2009, Vol 63, Num 3, pp 441-450, issn 0344-5704, 10 p.Article

Development of β-lapachone prodrugs fortherapy against human cancer cells with elevated NAD(P)H:Quinone oxidoreductase 1 levelsREINICKE, Kathryn E; BEY, Erik A; SUTTON, Damon et al.Clinical cancer research. 2005, Vol 11, Num 8, pp 3055-3064, issn 1078-0432, 10 p.Article

Phase I clinical and pharmacokinetic study of rebeccamycin analog NSC 655649 given daily for five consecutive daysDOWLATI, Afshin; HOPPEL, Charles L; INGALLS, Stephen T et al.Journal of clinical oncology. 2001, Vol 19, Num 8, pp 2309-2318, issn 0732-183XArticle

Phase II and pharmacokinetic/pharmacodynamic trial of sequential topoisomerase I and II inhibition with topotecan and etoposide in advanced non-small-cell lung cancerDOWLATI, Afshin; LEVITAN, Nathan; GORDON, Nahida H et al.Cancer chemotherapy and pharmacology. 2001, Vol 47, Num 2, pp 141-148, issn 0344-5704Article